Comparative Cost Analysis Of Intravenous And Subcutaneous Administration Of Rituximab In Lymphoma Patients

PURPOSE: The availability of different routes of administration of rituximab, with different dosing and times of infusion in the day care unit, raises the question of which formulation would be the best in terms of direct cost, particularly with the approval of new intravenous (IV) rituximab biosimi...

Descripción completa

Detalles Bibliográficos
Autores principales: Delgado Sánchez, Olga, Gutiérrez, Antonio, do Pazo, Fernando, Ginés, Jordi, Martorell, Clara, Boyeras, Bàrbara, Bento, Leyre, Garcia-Recio, Marta, Sampol, Antonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874115/
https://www.ncbi.nlm.nih.gov/pubmed/31819561
http://dx.doi.org/10.2147/CEOR.S212257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874115/
https://www.ncbi.nlm.nih.gov/pubmed/31819561
http://dx.doi.org/10.2147/CEOR.S212257

Ejemplares similares